1. Medicare Part B drug payments: impact of price substitutions based on 2021 average sales prices Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2023 Subject(s): Cost ControlDrug CostsGovernment RegulationMedicare Part BPrescription FeesUnited States
